Annual Retained Earnings
-$334.72 M
-$27.03 M-8.78%
December 31, 2023
Summary
- As of February 12, 2025, CRVS annual retained earnings is -$334.72 million, with the most recent change of -$27.03 million (-8.78%) on December 31, 2023.
- During the last 3 years, CRVS annual retained earnings has fallen by -$111.58 million (-50.00%).
- CRVS annual retained earnings is now -207798.76% below its all-time high of -$161.00 thousand, reached on December 31, 2014.
Performance
CRVS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$384.90 M
-$40.22 M-11.67%
September 30, 2024
Summary
- As of February 12, 2025, CRVS quarterly retained earnings is -$384.90 million, with the most recent change of -$40.22 million (-11.67%) on September 30, 2024.
- Over the past year, CRVS quarterly retained earnings has dropped by -$56.83 million (-17.32%).
- CRVS quarterly retained earnings is now -1411.95% below its all-time high of -$25.46 million, reached on September 30, 2015.
Performance
CRVS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CRVS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.8% | -17.3% |
| 3 y3 years | -50.0% | -25.1% |
| 5 y5 years | -96.3% | -25.1% |
CRVS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.6% | at low | -44.5% | at low |
| 5 y | 5-year | -54.1% | at low | -77.3% | at low |
| alltime | all time | <-9999.0% | at low | -1412.0% | at low |
Corvus Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$384.90 M(+11.7%) |
| Jun 2024 | - | -$344.68 M(+1.3%) |
| Mar 2024 | - | -$340.42 M(+1.7%) |
| Dec 2023 | -$334.72 M(+8.8%) | -$334.72 M(+2.0%) |
| Sep 2023 | - | -$328.06 M(+1.9%) |
| Jun 2023 | - | -$322.06 M(+2.1%) |
| Mar 2023 | - | -$315.56 M(+2.6%) |
| Dec 2022 | -$307.69 M(+15.5%) | -$307.69 M(+3.3%) |
| Sep 2022 | - | -$297.87 M(+5.2%) |
| Jun 2022 | - | -$283.04 M(+3.0%) |
| Mar 2022 | - | -$274.68 M(+3.1%) |
| Dec 2021 | -$266.38 M(+19.4%) | -$266.38 M(+3.6%) |
| Sep 2021 | - | -$257.14 M(+4.3%) |
| Jun 2021 | - | -$246.47 M(+5.0%) |
| Mar 2021 | - | -$234.72 M(+5.2%) |
| Dec 2020 | -$223.14 M(+2.8%) | -$223.14 M(-10.9%) |
| Sep 2020 | - | -$250.49 M(+4.1%) |
| Jun 2020 | - | -$240.69 M(+4.6%) |
| Mar 2020 | - | -$230.08 M(+6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -$217.15 M(+27.4%) | -$217.15 M(+5.4%) |
| Sep 2019 | - | -$206.10 M(+5.6%) |
| Jun 2019 | - | -$195.09 M(+7.1%) |
| Mar 2019 | - | -$182.12 M(+6.8%) |
| Dec 2018 | -$170.47 M(+38.0%) | -$170.47 M(+6.6%) |
| Sep 2018 | - | -$159.96 M(+7.0%) |
| Jun 2018 | - | -$149.47 M(+8.4%) |
| Mar 2018 | - | -$137.84 M(+11.6%) |
| Dec 2017 | -$123.53 M(+82.0%) | -$123.53 M(+10.7%) |
| Sep 2017 | - | -$111.61 M(+12.9%) |
| Jun 2017 | - | -$98.89 M(+17.9%) |
| Mar 2017 | - | -$83.91 M(+23.6%) |
| Dec 2016 | -$67.87 M(+115.5%) | -$67.87 M(+19.5%) |
| Sep 2016 | - | -$56.78 M(+22.1%) |
| Jun 2016 | - | -$46.49 M(+22.8%) |
| Mar 2016 | - | -$37.84 M(+20.2%) |
| Dec 2015 | -$31.50 M(>+9900.0%) | -$31.50 M(+23.7%) |
| Sep 2015 | - | -$25.46 M |
| Dec 2014 | -$161.00 K | - |
FAQ
- What is Corvus Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual retained earnings year-on-year change?
- What is Corvus Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly retained earnings year-on-year change?
What is Corvus Pharmaceuticals annual retained earnings?
The current annual retained earnings of CRVS is -$334.72 M
What is the all time high annual retained earnings for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual retained earnings is -$161.00 K
What is Corvus Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, CRVS annual retained earnings has changed by -$27.03 M (-8.78%)
What is Corvus Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of CRVS is -$384.90 M
What is the all time high quarterly retained earnings for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly retained earnings is -$25.46 M
What is Corvus Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, CRVS quarterly retained earnings has changed by -$56.83 M (-17.32%)